Results 251 to 260 of about 232,126 (306)

Complete genome sequence of human papillomavirus type 45 identified from a cervical cancer patient in Bangladesh. [PDF]

open access: yesMicrobiol Resour Announc
Tusar MTT   +14 more
europepmc   +1 more source

Initial evaluation of a new cervical screening strategy combining human papillomavirus genotyping and automated visual evaluation: the Human Papillomavirus-Automated Visual Evaluation Consortium. [PDF]

open access: yesJ Natl Cancer Inst
Befano B   +40 more
europepmc   +1 more source

Human Papillomavirus Vaccines

Reviews in Medical Virology, 2006
AbstractA wealth of epidemiological and molecular evidence has led to the conclusion that virtually all cases of cervical cancer and its precursor intra‐epithelial lesions are a result of infection with one or other of a subset of genital human papillomaviruses (HPVs) suggesting that prevention of infection by prophylactic vaccination would be an ...
Mia R, Schmiedeskamp, Denise R, Kockler
openaire   +5 more sources

Human papillomavirus

Current Opinion in Obstetrics and Gynecology, 1992
In the past year, new data have been published on the molecular biology of human papillomavirus infections and their relationship to cervical neoplasia. As molecular techniques have become more sophisticated and as the molecular knowledge of human papilloma-virus infections has been pursued in greater depth, it is increasingly apparent that this human ...
R M, Richart, T C, Wright
openaire   +2 more sources

Human papillomavirus vaccines

Seminars in Cancer Biology, 1999
Genital human papillomavirus (HPV) infections are the viral sexually transmitted diseases most frequently diagnosed that include anogenital condylomas and squamous intra-$bepithelial lesions, among which the precursors of invasive carcinomas of the uterine cervix.
F, Breitburd, P, Coursaget
openaire   +2 more sources

Human Papillomavirus Vaccines

Clinical Obstetrics & Gynecology, 2023
Human papillomavirus (HPV) vaccines are highly effective in preventing the transmission of HPV and thus downstream HPV-related lower genital tract neoplasias. First introduced in 2006, the HPV vaccine has demonstrated clinical efficacy in both men and women.
openaire   +2 more sources

Home - About - Disclaimer - Privacy